NVIV - InVivo Therapeutics Holdings Corp.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 510.11M
Enterprise Value 31.45M
Trailing P/E N/A
Forward P/E 1-14.07
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)21.93
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-0.06

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Dec 31, 2017

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-60.66%
Return on Equity (ttm)-136.95%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -23.3M
Net Income Avi to Common (ttm)-26.75M
Diluted EPS (ttm)-0.81
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)12.91M
Total Cash Per Share (mrq)0.34
Total Debt (mrq)852k
Total Debt/Equity (mrq)8.43
Current Ratio (mrq)4.44
Book Value Per Share (mrq)0.29

Cash Flow Statement

Operating Cash Flow (ttm)-19.68M
Levered Free Cash Flow (ttm)-12.09M

Trading Information

Stock Price History

Beta 1.89
52-Week Change 3-93.03%
S&P500 52-Week Change 310.49%
52 Week High 3102.00
52 Week Low 36.25
50-Day Moving Average 312.40
200-Day Moving Average 320.60

Share Statistics

Avg Vol (3 month) 326.76k
Avg Vol (10 day) 330.36k
Shares Outstanding 51.56M
Float 36.07M
% Held by Insiders 10.90%
% Held by Institutions 110.40%
Shares Short 31.31M
Short Ratio 311.45
Short % of Float 34.10%
Shares Short (prior month) 31.35M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/25
Last Split Date 3Apr 17, 2018